Tyrosine Replete
80/100
This product is generally safe
- Folate: 452mg is 452.0× the Tolerable Upper Intake Level (1.0mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Folate: 452mg is 452.0× the Tolerable Upper Intake Level (1.0mg)
Label Data
2 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
452 mcg DFE
(113% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 452.0× (UL: 1.0 mg)
📚 225 studies (Tier A: 10, B: 105)
1000 mg
📊 Market median: 500.0mg (223 products)
📚 22 studies (Tier A: 0, B: 1)
Other Ingredients
Vegetable Capsule
Rice Flour
Cellulose
Magnesium Stearate
Silicon Dioxide
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (98% of products)
Structure/Function (78% of products)
Nutrient (56% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Product Information
📋 Directions for Use
Directions: Take 1 or 2 capsules three times a day or as directed by your health care practitioner. Use only under medical supervision.
Use of CysReplete is recommended with this product to prevent sulfur amino acid depletion.
⚠️ Warnings & Precautions
If you are pregnant or nursing consult your health care practitioner before use.
Keep away from children.
🧪 Formulation Notes
Naturally sourced Tyrosine
Does not contain wheat, corn, soy, sucrose, salt, starch, yeast, artificial flavors, artificial colorings, or other known allergens.
This product is manufactured in a cGMP certified facility.
Gluten-free
Additional Information
This product is intended for resale.
Keep away from direct sunlight.
GF Gluten-free
Product Details
DSLD Entry Date
2021-08-23
Product Type
Other Combinations
Form
Capsule
Brand
CHK Nutrition
DSLD ID
252918
Data Updated
2026-04-11
Research Evidence
50
Research Sources
47
Avg Quality Score
28
Rct
13
Clinical Trial
5
Guideline
4
Systematic Review
A
Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
B
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
B
Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
B
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
B
[Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
B
Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
B
Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
C
Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Compare Similar Products
L-Tyrosine 500 mg
VitaCeutical Labs
100
Tyrosine
Vitabase
100
L-Tyrosine
Douglas Laboratories
100
L-Tyrosine 500 mg
Douglas Laboratories
100
N-Acetyl-L-Tyrosine 300
LifeLink
100